Docking compared to 3D-pharmacophores: The scoring function challenge

Drug Discovery Today: Technologies

Volumn 7, Issue 4, 2010, Pages

  Hein, Michael ^a   Zilian, David ^a   Sotriffer, Christoph A ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; MOLECULAR DOCKING; MOLECULAR MODEL; PHARMACOPHORE; SCORING SYSTEM; SCREENING TEST; STRUCTURE ANALYSIS; VIRTUAL SCREENING;

EID: 78650721465     PISSN: 17406749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddtec.2010.12.003     Document Type: Review

References (40)

1. Ripphausen, P. et al. (in press) Quo vadis, virtual screening? A comprehensive survey of prospective applications. J. Med. Chem, doi:10.1021/jm101020z
2. Markt, P. et al. (2011) Pharmacophore models for virtual screening. In Virtual Screening. Principles, Challenges, and Practical Guidelines (Sotriffer, C., ed.), Wiley-VCH
3. A.R. Leach Three-dimensional pharmacophore methods in drug discovery J. Med. Chem. 53 2010 539 558
4. S-Y. Yang Pharmacophore modeling and applications in drug discovery: challenges and recent advances Drug Discov. Today 15 2010 444 450
5. Howe, T. et al. (2011) Scenarios and case studies: examples for ligand-based virtual screening. In Virtual Screening. Principles, Challenges, and Practical Guidelines (Sotriffer, C., ed.), Wiley-VCH
6. M. Baroni A common reference framework for analyzing/comparing proteins and ligands. Fingerprints for Ligands and Proteins (FLAP): theory and application J. Chem. Inf. Model. 47 2007 279 294
7. R. Brenk Virtual screening for submicromolar leads of tRNA-guanine transglycosylase based on a new unexpected binding mode detected by crystal structure analysis J. Med. Chem. 46 2003 1133 1143
8. F. Ortuso GBPM: GRID-based pharmacophore model: concept and application studies to protein-protein recognition Bioinformatics 22 2006 1449 1455
9. C. Sotriffer, and G. Klebe Identification and mapping of small-molecule binding sites in proteins: computational tools for structure-based drug design Farmaco 57 2002 243 251
10. G. Wolber, and T. Langer LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters J. Chem. Inf. Model. 45 2005 160 169
11. G. Wolber Molecule-pharmacophore superpositioning and pattern matching in computational drug design Drug Discov. Today 13 2008 23 29
12. E. Perola, and P.S. Charifson Conformational analysis of drug-like molecules bound to proteins: an extensive study of ligand reorganization upon binding J. Med. Chem. 47 2004 2499 2510
13. Matter, H. and Sotriffer, C. (2011) Applications and success stories in virtual screening. In Virtual Screening. Principles, Challenges, and Practical Guidelines (Sotriffer, C., ed.), Wiley-VCH
14. S.G. Rohrer, and K. Baumann Maximum unbiased validation (MUV) data sets for virtual screening based on PubChem bioactivity data J. Chem. Inf. Model. 49 2009 169 184
15. T. Klabunde Sequence-derived three-dimensional pharmacophore models for G-protein-coupled receptors and their application in virtual screening J. Med. Chem. 52 2009 2923 2932
16. G. Colombo Non-peptidic thrombospondin-1 mimics as fibroblast growth factor-2 inhibitors: an integrated strategy for the development of new antiangiogenic compounds J. Biol. Chem. 285 2010 8733 8742
17. L. De Luca Pharmacophore-based discovery of small-molecule inhibitors of protein-protein interactions between HIV-1 integrase and cellular cofactor LEDGF/p75 ChemMedChem 4 2009 1311 1316
18. D.I. Kang Discovery of novel human phenylethanolamine N-methyltransferase (hPNMT) inhibitors using 3D pharmacophore-based in silico, biophysical screening and enzymatic activity assays Mol. Cells 29 2010 595 602
19. Y. Tanrikulu Structure-based pharmacophore screening for natural-product-derived PPARgamma agonists Chembiochem 10 2009 75 78
20. N.D. Kim Structure-based virtual screening of novel tubulin inhibitors and their characterization as anti-mitotic agents Bioorg. Med. Chem. 18 2010 7092 7100
21. N. Moitessier Towards the development of universal, fast and highly accurate docking/scoring methods: a long way to go Br. J. Pharmacol. 153 Suppl. 1 2008 S7 26
22. S.F. Sousa Protein-ligand docking: current status and future challenges Proteins 65 2006 15 26
23. H. Kubinyi Success stories of computer-aided design S. Edkins, Computer Applications in Pharmaceutical Research and Development 2006 Wiley 377 424
24. T. Cheng Comparative assessment of scoring functions on a diverse test set J. Chem. Inf. Model. 49 2009 1079 1093
25. G.L. Warren A critical assessment of docking programs and scoring functions J. Med. Chem. 49 2006 5912 5931
26. J.J. Irwin Community benchmarks for virtual screening J. Comput. Aided Mol. Des. 22 2008 193 199
27. C.A. Sotriffer SFCscore: scoring functions for affinity prediction of protein-ligand complexes Proteins 73 2008 395 419
28. P.S. Charifson Consensus scoring: a method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins J. Med. Chem. 42 1999 5100 5109
29. M. Stahl, and M. Rarey Detailed analysis of scoring functions for virtual screening J. Med. Chem. 44 2001 1035 1042
30. M.H. Seifert Targeted scoring functions for virtual screening Drug Discov. Today 14 2009 562 569
31. W. Xu Novel non-peptide beta-secretase inhibitors derived from structure-based virtual screening and bioassay Bioorg. Med. Chem. Lett. 19 2009 3188 3192
32. H. Park Structure-based virtual screening approach to identify novel classes of Cdc25B phosphatase inhibitors Bioorg. Med. Chem. Lett. 19 2009 4372 4375
33. S. Ko Structure-based virtual screening approach to the discovery of novel inhibitors of factor-inhibiting HIF-1. Identification of new chelating groups for the active-site ferrous ion Bioorg. Med. Chem. 17 2009 7769 7774
34. H. Li Identification of novel falcipain-2 inhibitors as potential antimalarial agents through structure-based virtual screening J. Med. Chem. 52 2009 4936 4940
35. K.P. Ravindranathan Discovery of novel fibroblast growth factor receptor 1 kinase inhibitors by structure-based virtual screening J. Med. Chem. 53 2010 1662 1672
36. M. Okamoto Identification of death-associated protein kinases inhibitors using structure-based virtual screening J. Med. Chem. 52 2009 7323 7327
37. S. Nagarajan IKK[beta] inhibitors identification part I. Homology model assisted structure based virtual screening Bioorg. Med. Chem. 17 2009 2759 2766
38. J. Sopkova-de Oliveira Santos Virtual screening discovery of new acetylcholinesterase inhibitors issued from CERMN chemical library J. Chem. Inf. Model. 50 2010 422 428
39. Z. Chen Pharmacophore-based virtual screening versus docking-based virtual screening: a benchmark comparison against eight targets Acta Pharmacol. Sin. 30 2009 1694 1708
40. M. Totrov, and R. Abagyan Flexible ligand docking to multiple receptor conformations: a practical alternative Curr. Opin. Struct. Biol. 18 2008 178 184